Chinese Journal of Dermatology ›› 2026, e20240319.doi: 10.35541/cjd.20240319
• Reviews • Previous Articles Next Articles
Tang Dongmei1, Yan Yurou2, Xu Yinde2, Li Xiaolan2
Received:2024-06-18
Revised:2026-06-07
Online:2026-02-09
Published:2026-09-22
Contact:
冬梅 唐
Tang Dongmei, Yan Yurou, Xu Yinde, Li Xiaolan. The role of tissue-resident memory T cells in the recurrence of autoimmune skin diseases[J]. Chinese Journal of Dermatology,2026,e20240319. doi:10.35541/cjd.20240319
| [1] | Osman M, Park SL, Mackay LK. Tissue⁃resident memory T (TRM ) cells: front⁃line workers of the immune system[J]. Eur J Immunol, 2023,53(11):e2250060. DOI: 10.1002/eji.202250060. |
| [2] | Li L, Liu P, Chen C, et al. Advancements in the characterization of tissue resident memory T cells in skin disease[J]. Clin Immunol. 2022,245(12):109183. DOI: 10.1016/j.clim.2022.109183. |
| [3] | Dong C, Lin L, Du J. Characteristics and sources of tissue⁃resident memory T cells in psoriasis relapse[J]. Curr Res Immunol, 2023,4:100067. DOI: 10.1016/j.crimmu.2023.100067. |
| [4] | Chen L, Shen Z. Tissue⁃resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders[J]. Cell Mol Immunol, 2020,17(1):64⁃75. DOI: 10. 1038/s41423⁃019⁃0291⁃4. |
| [5] | Jan PN, Jana DA, Silvia AV, et al. CCR4 in cutaneous T⁃cell lymphoma: therapeutic targeting of a pathogenic driver[J]. European journal of immunology, 2021,51(7):1660⁃1671. |
| [6] | McCully ML, Ladell K, Andrews R, et al. CCR8 expression defines tissue⁃resident memory T cells in human skin[J]. J Immunol, 2018,200(5):1639⁃1650. DOI: 10.4049/jimmunol. 1701377. |
| [7] | Tokura Y, Phadungsaksawasdi P, Kurihara K, et al. Pathophysiology of skin resident memory T cells[J]. Front Immunol, 2020,11:618897. DOI: 10.3389/fimmu.2020.618897. |
| [8] | Zhu HQ, Xu QN. The roles of skin⁃resident memory T cells in dermatoses[J]. Int J Dermatol Venerol, 2019,2(1):29⁃32. DOI:10.3760/cma.j.issn.2096⁃5540.2019.01.006. |
| [9] | 甘奕传, 张三泉, 张锡宝. Treg、γδT和TRM细胞在斑块状银屑病免疫病理机制中的研究进展[J]. 中国皮肤性病学杂志, 2023,37(11):1328⁃1333. DOI: 10.13735/j.cjdv.1001⁃7089.2021 12103. |
| [10] | Frączek A, Owczarczyk⁃Saczonek A, Placek W. The role of Trm cells in the pathogenesis of vitiligo⁃a review of the current state⁃of⁃the⁃art[J]. Int J Mol Sci, 2020,21(10):3552. DOI: 10.3390/ijms21103552. |
| [11] | Zitti B, Hoffer E, Zheng W, et al. Human skin⁃resident CD8+ T cells require RUNX2 and RUNX3 for induction of cytotoxicity and expression of the integrin CD49a[J]. Immunity, 2023,56(6):1285⁃1302. DOI: 10.1016/j.immuni.2023.05.003. |
| [12] | Tian D, Lai Y. The relapse of psoriasis: mechanisms and mysteries[J]. JID Innov, 2022,2(3):100116. DOI: 10.1016/j.xjidi.2022.100116. |
| [13] | Kasprowicz⁃Furmańczyk M, Czerwińska J, Placek W, et al. Assessment of the tissue resident memory cells in lesional skin of patients with psoriasis and in healthy skin of healthy volunteers[J]. Int J Environ Res Public Health, 2021,18(21):1251. DOI: 10.3390/ijerph182111251. |
| [14] | Whitley SK, Li M, Kashem SW, et al. Local IL⁃23 is required for proliferation and retention of skin⁃resident memory TH17 cells[J]. Sci Immunol, 2022,7(77):eabq3254. DOI: 10.1126/sciimmunol.abq3254. |
| [15] | Flora A, Frew JW. A case series of early biologic therapy in guttate psoriasis: targeting resident memory T cell activity as a potential novel therapeutic modality[J]. JAAD Case Rep, 2022,24(5):82⁃87. DOI: 10.1016/j.jdcr.2022.04.019. |
| [16] | Lu J, Huang D, Yang N, et al. Better efficacy, lower recurrence rate and decreased CD8+TRM with guselkumab treatment for generalized pustular psoriasis: a prospective cohort study from China[J]. Clin Immunol, 2024,259:109899. DOI: 10.1016/j.clim.2024.109899. |
| [17] | Boniface K, Jacquemin C, Darrigade AS, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3[J]. J Invest Dermatol, 2018,138(2):355⁃364. DOI: 10.1016/j.jid.2017.08.038. |
| [18] | Ng CY, Chan YP, Chiu YC, et al. Targeting the elevated IFN⁃γ in vitiligo patients by human anti⁃ IFN⁃γ monoclonal antibody hampers direct cytotoxicity in melanocyte[J]. J Dermatol Sci, 2023,110(3):78⁃88. DOI: 10.1016/j.jdermsci.2023.04.006. |
| [19] | Richmond JM, Strassner JP, Zapata L, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo[J]. Sci Transl Med, 2018,10(450):7710. DOI: 10.1126/scitranslmed.aam7710. |
| [20] | Bhardwaj S, Rani S, Kumaran MS, et al. Expression of Th17⁃ and Treg⁃specific transcription factors in vitiligo patients[J]. Int J Dermatol, 2020,59(4):474⁃481. DOI: 10.1111/ijd.14766. |
| [21] | Chen J, Wang X, Cui T, et al. Th1⁃like Treg in vitiligo: an incompetent regulator in immune tolerance[J]. J Autoimmun,2022,131:102859. DOI:10.1016/j.jaut.2022.102859. |
| [22] | Shah F, Giri PS, Bharti AH, et al. Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM⁃regulatory T cells in generalized vitiligo patients[J]. Exp Dermatol, 2024,33(1):e14982. DOI: 10.1111/exd.14982. |
| [23] | Vale E, Garcia LC. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects[J]. An Bras Dermatol, 2023,98(3):355⁃372. DOI: 10.1016/j.abd. 2022.09.005. |
| [24] | Gu HJ, Song S, Roh JY, et al. Expression pattern of tissue⁃resident memory T cells in cutaneous lupus erythematosus[J]. Lupus, 2021,30(9):1427⁃1437. DOI: 10.1177/09612033211017218. |
| [25] | Zhao Z, Zhu H, Li Q, et al. Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases[J]. J Autoimmun, 2022,128:102811. DOI: 10.1016/j.jaut.2022.102811. |
| [26] | Ryan GE, Harris JE, Richmond JM. Resident memory T cells in autoimmune skin diseases[J]. Front Immunol, 2021,12:652191. DOI: 10.3389/fimmu.2021.652191. |
| [27] | Zhou M, Guo C, Li X, et al. JAK/STAT signaling controls the fate of CD8+CD103+ tissue⁃resident memory T cell in lupus nephritis[J]. J Autoimmun, 2020,109:102424. DOI: 10.1016/j.jaut.2020. 102424. |
| [28] | Ishii N. Significance of anti⁃desmocollin autoantibodies in pemphigus[J]. J Dermatol, 2023,50(2):132⁃139. DOI: 10.1111/1346⁃8138.16660. |
| [29] | Schmidt E, Kasperkiewicz M, Joly P. Pemphigus[J]. Lancet, 2019,394(10201):882⁃894. DOI: 10.1016/S0140⁃6736(19)31778⁃7. |
| [30] | Fang H, Li Q, Wang G. The role of T cells in pemphigus vulgaris and bullous pemphigoid[J]. Autoimmun Rev, 2020,19(11):102661. DOI: 10.1016/j.autrev.2020.102661. |
| [31] | Zou Y, Yuan H, Zhou S, et al. The pathogenic role of CD4+ tissue⁃resident memory T cells bearing T follicular helper⁃like phenotype in pemphigus lesions[J]. J Invest Dermatol, 2021,141(9):2141⁃2150. DOI: 10.1016/j.jid.2021.01.030. |
| [32] | Haughton RD, Herbert SM, Ji⁃Xu A, et al. Janus kinase inhibitors for alopecia areata: a narrative review[J]. Indian J Dermatol Venereol Leprol, 2023,89(6):799⁃806. DOI: 10.25259/IJDVL_1093_2022. |
| [33] | Axel De Greef, Romane Thirion, Pierre⁃Dominique Ghislain, et al. Real⁃life effectiveness and tolerance of baricitinib for the treatment of severe alopecia areata with 1⁃year follow⁃up data[J]. Dermatol Ther,2023,13(11):2869⁃2877. DOI:10.1007/s13555⁃023⁃01030⁃x. |
| [34] | Malhotra K, Madke B. An updated review on current treatment of alopecia areata and newer therapeutic options[J]. Int J Trichology, 2023,15(1):3⁃12. DOI: 10.4103/ijt.ijt_28_21. |
| [35] | 刘元香, 梁源, 赵欣荣, 等. JAK抑制剂治疗儿童重症斑秃5例[J]. 中华皮肤科杂志, 2023,56(9):849⁃852. DOI: 10.35541/cjd.20220317. |
| [36] | Del Duca E, Ruano Ruiz J, Pavel AB, et al. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing[J]. Br J Dermatol, 2020,183(6):1083⁃1093. DOI: 10.1111/bjd.19040. |
| [37] | Hashimoto K, Yamada Y, Fujikawa M, et al. Altered T cell subpopulations and serum anti⁃TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model[J]. J Dermatol Sci, 2021,104(1):21⁃29. DOI: 10. 1016/j.jdermsci.2021.09.001. |
| [1] | Chen Xingyu, Yao Xu. Role of neutrophils in inflammatory dermatoses [J]. Chinese Journal of Dermatology, 2026, 59(9): 905-910. |
| [2] | Ma Jing, Luan Chao, Chen Kun. Lipid metabolism-related proteins in psoriasis [J]. Chinese Journal of Dermatology, 2026, 59(9): 915-918. |
| [3] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on the long-term management of plaque psoriasis with biologic agents (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(9): 827-843. |
| [4] | Tang Zhen¹, Liu Yuhang¹, Yang Ling², Hu Lingxue¹, He Zhijie¹, Cao Kai¹, Ding Shu¹. Value and features of reflectance confocal microscopy in the diagnosis and differential diagnosis of cutaneous lupus erythematosus [J]. Chinese Journal of Dermatology, 2026, 59(9): 873-880. |
| [5] | Zhang Hanmei, Feng Suying. Gut, skin, and oral microbiota in autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2026, 59(9): 902-905. |
| [6] | Shi Rongcan¹, ², Yu Zengyang², ³, Luo Qingqiong², Ma Rui¹, ², Jiang Xingyu¹, ², Wang Yuanyuan¹, ², Cai Jiangluyi¹, ², Shi Yuling¹, ². Palmitoyl-proteomic profiles of psoriatic lesions and their role in inflammatory responses: a preliminary study [J]. Chinese Journal of Dermatology, 2026, 59(8): 738-749. |
| [7] | Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement ( edition)”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727. |
| [8] | Ji Xiang, Zhu Ping, Huang Shudai, Jiang Jiayi, Huang Kaixuan, Li Zhexi, Yang Xi, Wang Daguang. Analysis of risk factors for autoimmune bullous diseases complicated by venous thromboembolism during hospitalization: a retrospective analysis [J]. Chinese Journal of Dermatology, 2026, 59(8): 779-782. |
| [9] | Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases [J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674. |
| [10] | Yuwen Tianyi¹, Zhou Zizhen¹, Tian Jingyu¹, Chen Sihan², Li Min², Zhang Fengyuan¹, Gu Heng, ², Chen Xu, ². Expression of the glutaminase 1/ammonia metabolism axis in keratinocytes in ultraviolet B-induced acute skin injury and psoriatic skin inflammation [J]. Chinese Journal of Dermatology, 2026, 59(7): 654-661. |
| [11] | Hu Yu, Lu Yan, Chen Kun, Gu Heng. Standardization, precision, and full-cycle management: interpretation of Specifications for the Management of Vitiligo Patients Undergoing Home Phototherapy [J]. Chinese Journal of Dermatology, 2026, 59(7): 632-636. |
| [12] | Chen Tingnan, Liang Jingyao, Deng Shilin, Shu Zhirong, Zhang Xibao. Immunophenotypic switching between psoriasis and atopic dermatitis after biologic therapy: a systematic review of clinical features, mechanisms and management strategies [J]. Chinese Journal of Dermatology, 2026, 59(5): 474-481. |
| [13] | Zhang Xiaoxu, Luo Suju. Efficacy and safety of upadacitinib in the treatment of six cases of palmoplantar pustulosis [J]. Chinese Journal of Dermatology, 2026, 59(5): 459-463. |
| [14] | Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology. Expert consensus on the diagnosis, treatment and rehabilitation of psoriasis in the elderly (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 407-418. |
| [15] | Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on fecal microbiota transplantation in the treatment of psoriasis (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(5): 427-435. |
|